Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2025-12-26 @ 10:36 AM
NCT ID:
NCT01308528
Brief Summary:
The purpose of this study is to compare the safety and security and efficacy of sodium enoxaparin Cristália Produtos QuĂmicos Farmaceuticos Ltda - Endocris with Clexane (Sanofi-Aventis) to prevent Venous Thromboembolism in Patients With High-Risk to Develop Thromboembolic Disease Undergoing Geral Abdominal Surgery.
Detailed Description:
This study is a requirement of Anvisa to add a new indication for off-label drug
Study:
NCT01308528
Study Brief:
Protocol Section:
NCT01308528